Aqua Bio Technology ASA · OSL:ABTEC
Aqua Bio Technology ASA — Q1 2014 Earnings Presentation
14 slides from Aqua Bio Technology ASA's earnings presentation, May 21, 2014
Slide 1: First Quarter 2014 Results Presentation
First Quarter 2014 Results Presentation 21 May 2014 1
Slide 2: A unique technology in the fastest growing segment
A unique technology. In the fastest growing segment of a rapidly growing industry. Welcome to Aqua Bio Technology. 2
Slide 3: Q1 2014 Highlights
Q1 2014 Highlights • Exclusivity and royalty payments received according to contracts – Product sales income slightly improving from two previous quarters • Dermaclarine™ being rolled out globally – New distributors provide extended market reach • Profits down from record quarter Q1 13, yet improved
Slide 4: 1st Quarter 2014 Results
1st Quarter 2014 Results NOK million Q1 2014 Q1 2013 2013 Income 5.4 7.2 22.8 Operating costs -4.2 -3.3 -15.0 EBITDA 1.2 3.9 7.8 EBIT -0.4 2.6 1.8 EBT -0.4 2.7 2.8 Net result -0.4 2.7 2.8 EBITDA margin 21.6% 54.1% 34.2% Revenues will fluctuate from quarter to quarter, due to ABT’s early phase posi
Slide 5: Income development last six quarters
Income development last six quarters 8000 7000 6000 5000 4000 Sales Other income 3000 2000 1000 0 Q4 12 Q1 13 Q2 13 Q3 13 Q4 13 Q1 14 5
Slide 6: Balance Sheet
Balance Sheet NOK million 31 Mar 2014 31 Dec 2013 31 Mar 2013 Fixed assets 16.4 16.6 20.7 Current assets 60.5 61.7 56.3 - of which is cash 26.6 27.0 17.6 Total equity 65.6 65.9 64.8 Long term debt 8.5 9.0 9.6 Short term debt 2.8 3.4 2.7 Total balance 76.9 78.3 77.1 Equity ratio 85.3% 84.2% 84.0%
Slide 7: Cash flow
Cash flow NOK million (Year to date) 2014 2013 Cash at beginning of period 27.0 21.0 From operations 1.5 -3.1 From investments -1.4 -0.2 From financing -0.6 -0.1 Cash at end of period 26.6 17.6 Cash change in period -0.4 -3.4
Slide 8: Strategy: Rejuvenating the skin care industry
Strategy: Rejuvenating the skin care industry 1. Further develop unique position in marine, sustainable ingredients Maintain strong IP protection of proprietary technology 2. Multiple approach to marketing and distribution Visibility in industry meeting places Direct dialogue with industry maj
Slide 9: ABT well adapted to industry growth trends
ABT well adapted to industry growth trends Skin care is the largest and fastest growing product class globally Due to an increased demand for activity and efficacy, the specialty actives market is expected to grow faster than the rest of the overall personal care industry Specialty actives in
Slide 10: Q1 2014 operational update
Q1 2014 operational update Aquabeautine XL Dermaclarine Complaint filed with US court by Additional distributor agreements signed exclusivity partner Restorsea Global distributor network build-up close Amway’s Artistry skin care series performs to completion well after Q4 launch in Asia Paci
Slide 11: Restorsea lawsuit update
Restorsea lawsuit update Restorsea filed complaint with New York court on 7 February 2014 Alleged breach of contract, more than USD 5.9 million damage claim ABT finds lawsuit substantively and procedurally deficient Court dismissal requested by ABT Dialogue with Restorsea is established
Slide 12: Outlook
Outlook • Attractive market outlook – A unique technology, in the fastest growing segment of a rapidly growing industry – ABT well adapted to industry’s sustainability trend • Growing revenues expected – 2014-2017 contracted income stream substantial – Increasing product sales and new products repre
Slide 13: 2nd Quarter 2014 Results 20 August 2014
2nd Quarter 2014 Results 20 August 2014
Slide 14: Investor contact
Investor contact Arvid Lindberg, CEO +47 9824 5410 [email protected] www.aquabiotechnology.com